Douglas Tsao
Stock Analyst at HC Wainwright & Co.
(0.9)
# 2049
Out of 5,329 analysts
612
Total ratings
34.70%
Success rate
-6.41%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
PRAX Praxis Precision Med... | Reiterates: Buy | 105 105 | 38.16 | 175.16% | 23 | May 1, 2025 | |
CHRS Coherus BioSciences | Reiterates: Buy | 7 7 | 1.03 | 579.61% | 25 | Apr 29, 2025 | |
RZLT Rezolute | Reiterates: Buy | 14 14 | 3.96 | 253.54% | 17 | Apr 28, 2025 | |
VRDN Viridian Therapeutic... | Reiterates: Buy | 34 34 | 13.74 | 147.45% | 16 | Apr 23, 2025 | |
ROIV Roivant Sciences | Reiterates: Buy | 18 18 | 11.59 | 55.31% | 18 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 720 720 | 638.88 | 12.7% | 36 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 80 80 | 45.16 | 77.15% | 31 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 27 27 | 11.86 | 127.66% | 27 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 19 19 | 14.7 | 29.25% | 4 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 12 | 2.96 | 305.41% | 17 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 25 25 | 1.26 | 1884.13% | 25 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 18 18 | 2.54 | 608.66% | 14 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 51 51 | 15.96 | 219.55% | 22 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 18 18 | 0.77 | 2237.66% | 7 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 54 54 | 22.56 | 139.36% | 14 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 57 57 | 20.09 | 183.72% | 26 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 15 15 | 10.39 | 44.37% | 15 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 5 5 | 1.67 | 199.4% | 14 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 53 53 | 38.18 | 38.82% | 4 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 30 3 | 1.58 | 89.87% | 16 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 46 46 | 30.63 | 50.18% | 23 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 14 12 | 7.5 | 60% | 22 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 118 118 | 49.68 | 137.52% | 14 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 81 81 | 33.6 | 141.07% | 23 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 5 5 | n/a | n/a | 10 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 2 2 | n/a | n/a | 19 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 7 7 | n/a | n/a | 19 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 8 8 | 4.23 | 89.13% | 9 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 360 360 | n/a | n/a | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 41 45 | n/a | n/a | 6 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 3 | n/a | n/a | 2 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 6 | n/a | n/a | 3 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 3 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 74 | n/a | n/a | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 10 | 1.41 | 609.22% | 5 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 48 30 | n/a | n/a | 2 | Mar 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 5 | n/a | n/a | 1 | Dec 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 23 10 | 29.38 | -65.96% | 7 | Dec 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 162 220 | n/a | n/a | 5 | Feb 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 14 14 | n/a | n/a | 6 | Oct 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 53 | n/a | n/a | 9 | Aug 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 11 10 | n/a | n/a | 7 | Aug 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 168 182 | 145.22 | 25.33% | 4 | Feb 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 19 | 6.91 | 171.35% | 2 | Jan 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 25 18 | 18.65 | -3.49% | 3 | Aug 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 5 | n/a | n/a | 5 | Aug 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Underweight | 8 | 15.63 | -48.82% | 7 | Jun 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 26 | n/a | n/a | 3 | Jun 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 52 | 26.78 | 94.17% | 2 | Jun 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 34 0 | n/a | n/a | 6 | Jun 6, 2018 |